A PHASE-II CLINICAL-TRIAL OF ADOPTIVE IMMUNOTHERAPY FOR ADVANCED RENAL-CELL CARCINOMA USING MITOGEN-ACTIVATED AUTOLOGOUS LEUKOCYTES AND CONTINUOUS INFUSION INTERLEUKIN-2

被引：32
作者：
WANG, JCL
WALLE, A
NOVOGRODSKY, A
SUTHANTHIRAN, M
SILVER, RT
BANDER, NH
RUBIN, AL
STENZEL, KH
机构：
[1] ROGOSIN INST,NEW YORK,NY
[2] NEW YORK HOSP,DEPT BIOCHEM,NEW YORK,NY 10021
[3] NEW YORK HOSP,DEPT SURG UROL,NEW YORK,NY 10021
[4] CORNELL UNIV,MED CTR,COLL MED,NEW YORK,NY 10021
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1989年 / 7卷 / 12期
关键词：
D O I：
10.1200/JCO.1989.7.12.1885
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1885 / 1891
页数：7
相关论文
共 11 条
[1]   METASTATIC RENAL-CANCER TREATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS - A PHASE-II CLINICAL-TRIAL [J].
FISHER, RI ;
COLTMAN, CA ;
DOROSHOW, JH ;
RAYNER, AA ;
HAWKINS, MJ ;
MIER, JW ;
WIERNIK, P ;
MCMANNIS, JD ;
WEISS, GR ;
MARGOLIN, KA ;
GEMLO, BT ;
HOTH, DF ;
PARKINSON, DR ;
PAIETTA, E .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (04) :518-523
[2]  
MUSS HB, 1987, SEMIN ONCOL, V14, P36
[3]  
NOVOGRODSKY A, 1977, J IMMUNOL, V118, P852
[4]  
PAULSON DF, 1985, CANCER PRINCIPLES PR, P895
[5]   A PROGRESS REPORT ON THE TREATMENT OF 157 PATIENTS WITH ADVANCED CANCER USING LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 OR HIGH-DOSE INTERLEUKIN-2 ALONE [J].
ROSENBERG, SA ;
LOTZE, MT ;
MUUL, LM ;
CHANG, AE ;
AVIS, FP ;
LEITMAN, S ;
LINEHAN, WM ;
ROBERTSON, CN ;
LEE, RE ;
RUBIN, JT ;
SEIPP, CA ;
SIMPSON, CG ;
WHITE, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (15) :889-897
[6]   OBSERVATIONS ON THE SYSTEMIC ADMINISTRATION OF AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2 TO PATIENTS WITH METASTATIC CANCER [J].
ROSENBERG, SA ;
LOTZE, MT ;
MUUL, LM ;
LEITMAN, S ;
CHANG, AE ;
ETTINGHAUSEN, SE ;
MATORY, YL ;
SKIBBER, JM ;
SHILONI, E ;
VETTO, JT ;
SEIPP, CA ;
SIMPSON, C ;
REICHERT, CM .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (23) :1485-1492
[7]  
ROSENSTEIN M, 1986, J IMMUNOL, V137, P1735
[8]   STRUCTURE AND EXPRESSION OF A CLONED CDNA FOR HUMAN INTERLEUKIN-2 [J].
TANIGUCHI, T ;
MATSUI, H ;
FUJITA, T ;
TAKAOKA, C ;
KASHIMA, N ;
YOSHIMOTO, R ;
HAMURO, J .
NATURE, 1983, 302 (5906) :305-310
[9]   ADOPTIVE IMMUNOTHERAPY FOR STAGE-IV RENAL-CELL CARCINOMA - A NOVEL PROTOCOL UTILIZING PERIODATE AND INTERLEUKIN-2-ACTIVATED AUTOLOGOUS LEUKOCYTES AND CONTINUOUS INFUSIONS OF LOW-DOSE INTERLEUKIN-2 [J].
WANG, J ;
WALLE, A ;
GORDON, B ;
NOVOGRODSKY, A ;
SUTHANTHIRAN, M ;
RUBIN, AL ;
MORRISON, H ;
SILVER, RT ;
STENZEL, KH .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (06) :1016-1023
[10]  
WANG J, 1986, J IMMUNOL, V136, P4735
12